🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
IQV
NYSE
🇺🇸 US
IQVIA Holdings Inc.
Healthcare
30Score
DipBuster Score™
$203.90
$2.36 (-1.14%)
Live price · Source: Yahoo
52-Week Position
$154.50
53% of range
$247.05
Beta
1.2
Moderate
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta1.2
52W High$247.05
52W Low$154.50
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (53% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position53% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta1.2
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at IQVIA Holdings Inc. (IQV), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-05-07 | Wims Morris Leslie | BUY | 171 |
| 2026-05-07 | Fasano Jim | BUY | 228 |
| 2026-05-07 | Goggins Colleen A | BUY | 214 |
| 2026-05-07 | Danhakl John G | BUY | 185 |
| 2026-04-23 | Stamps Sheila A | BUY | 1,571 |
| 2026-04-23 | Wims Morris Leslie | BUY | 1,571 |
| 2026-04-23 | Kaelin William G Jr | BUY | 1,571 |
| 2026-04-23 | Leonard John M | BUY | 1,571 |
| 2026-04-23 | Fasano Jim | BUY | 1,571 |
| 2026-04-23 | Burt Carol | BUY | 1,571 |
Valuation
P/E RatioN/A
Market CapN/A
Beta1.2
Dividend/yrNone
52W High$247.05
52W Low$154.50
52-Week Range
$154.50Now$247.05
53% through annual range
From 52W High−17.5%
From 52W Low+32%
📖 Plain English Summary
IQVIA Holdings Inc. is at 53% of its 52-week range. Beta 1.2 — moves broadly in line with the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for IQV
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — IQV
Heuristic · balance sheet, insider filings, price data, academic research
IQVIA Holdings Inc. — DipBuster Score 30/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track IQVIA Holdings Inc. free
Add IQV to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
19/25
Momentum & Volume
6/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
10
/100 · NEUTRAL
dip depth
10/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 30/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americ…
Sector
Healthcare
Market
🇺🇸 US
CEO
Ari Bousbib
Staff
93,000 employees
Website